Wockhardt Share Price
(WOCKPHARMA)
Check the latest share price of Wockhardt, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹1363.7
as on 04:01PM, 29 Apr 2025
NSE
Wockhardt Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹1,350Day's Price Range₹1,42752 Week's Low
52 Week's High
₹490.1552-Week Price Range₹1,679.9
| Returns % | |
| 1 Month Return | + 2.28 % |
| 3 Month Return | -1.37 % |
| 1 Year Return | + 140.17 % |
| Market Stats | |
| Previous Close | ₹1,391.50 |
| Open | ₹1,399.00 |
| Volume | 2.89L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹21,434.28Cr |
Wockhardt Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹21,434.28 Cr
P/B Ratio
1.72
EPS (TTM)
-19.38
Sector
Pharmaceuticals
How to invest in Wockhardt
Investing in Wockhardt is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Wockhardt or WOCKPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Wockhardt or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Wockhardt with just a few clicks!
Wockhardt Valuation
Track how the P/E of Wockhardt has moved over time to understand valuation trends.
Wockhardt in the last 5 years
Lowest (-94.57x)
October 8, 2021
Today (-11.63x)
December 15, 2023
Industry (58.33x)
December 15, 2023
Highest (12.70x)
May 26, 2021
Today’s Price to Earnings Ratio: -11.63x
Wockhardt Financials
Get the annual and quarterly financial summary of Wockhardt, including revenue, profit, loss and more.
Wockhardt Index Inclusions
Wockhardt Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Wockhardt.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.31% | 0.00 | |
| Foreign Institutions | 2.77% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 37.69% | 0.00 | |
| Others | 0.23% | 0.00 |
Wockhardt vs Peers
Compare market cap, revenue, PE, and other key metrics of Wockhardt with its industry peers.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹21,434.28 Cr | 91.89% | 0.74 | NA | NA | |
| BUY | ₹29,264.79 Cr | 142.95% | 0.53 | NA | NA | |
| NA | ₹14,628.52 Cr | 41.85% | 0.64 | NA | NA | |
| BUY | ₹15,546.04 Cr | 48.01% | 0.73 | NA | NA | |
| BUY | ₹21,699.41 Cr | 158.35% | 0.55 | NA | NA |
Wockhardt News & Key Events
Latest news and events at one place to help you take investing decisions in Wockhardt.
Wockhardt Faces Tariff Challenges Amid Breakthroughs - 12 Apr, 2025
Dr. Huzaifa Khorakiwala of Wockhardt Ltd highlighted potential challenges from US tariffs on Indian pharma. Despite this, Wockhardt leads in antibiotic research, with promising results from its WCK-5222-ZENIC trial.Wockhardt to Exit US Generics Business - 07 Apr, 2025
Wockhardt has announced its decision to exit the remaining US generics business for commercial reasons. The company reported a loss of ₹7 crore in Q3FY24 due to restructuring. Shares fell by 10% to ₹1,212.80.Wockhardt Shifts Focus to Novel Antibiotics and Biosimilars - 03 Apr, 2025
Wockhardt Ltd is pivoting from generics to novel antibiotics, seeking FDA approval for Zaynich, which shows promising results. The company anticipates significant revenue growth with new drugs and a turnaround in profitability.Wockhardt Shares Surge After Zaynich Success - 01 Apr, 2025
Wockhardt's shares climbed nearly 3% following the successful compassionate use of its antibiotic Zaynich in treating a 15-year-old cancer patient with a severe infection. This marks the third successful case for Zaynich, which has shown promise against drug-resistant infections and completed Phase III trials.Wockhardt Shares Surge on Drug Efficacy News - 19 Mar, 2025
Wockhardt Pharmaceuticals' shares hit a 5% upper circuit at ₹1,421 after its Zaynich drug demonstrated a 96.8% clinical cure rate in a Phase III study. The stock has risen 162% over the past year, outperforming benchmarks and peers.
Insights on Wockhardt Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, WOCKPHARMA stock has moved up by 26.6%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -22.0 Cr → 14.0 Cr (in ₹), with an average increase of 257.1% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 6.54% to 6.81% in Mar 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 7.13% to 7.56% in Mar 2025 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, WOCKPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.09% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 34.53% to 33.50% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 818.0 Cr → 729.0 Cr (in ₹), with an average decrease of 10.9% per quarter
About Wockhardt
Revenue: ₹739.00Cr as on June 2024 (Q2 24)
Net Profit: ₹-16.00Cr as on June 2024 (Q2 24)
Listing date: 23 Feb, 2000
Chairperson Name: H F Khorakiwala
| Organisation | Wockhardt |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Wockhardt
Check out the Mutual Funds with significant holdings in Wockhardt.
Futures and Options
View the latest movement in Wockhardt Futures & Options, including strike prices, expiry dates, and percentage changes.
FAQs
What is Wockhardt Ltd price today?
Wockhardt Ltd share price today stands at ₹1363.7, Open: ₹1399, Previous Close: ₹1391.5, High: ₹1427, Low: ₹1350, 52 Week High: ₹1679.9, 52 Week Low: ₹490.15.
How to Buy Wockhardt Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Wockhardt Ltd shares
What are today's traded volumes of Wockhardt Ltd?
Today's traded volume of Wockhardt Ltd(WOCKPHARMA) is 2.89L.
What is today's market capitalisation of Wockhardt Ltd?
Today's market capitalisation of Wockhardt Ltd(WOCKPHARMA) is ₹21,434.28 Cr.
What is the 52 Week High and Low Range of Wockhardt Ltd?
How much percentage Wockhardt Ltd is down from its 52 Week High?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1363.7. It is down -18.82% from its 52 Week High price of ₹1679.9
How much percentage Wockhardt Ltd is up from its 52 Week low?
Wockhardt Ltd (WOCKPHARMA) share price is ₹1363.7. It is up 178.22% from its 52 Week Low price of ₹490.15